Dr. Costigan's ongoing support of NuVasive and his dedication to incorporating innovative technologies into his practice highlight his forward-thinking mindset. His investments in cutting-edge biologics solutions align seamlessly with NANISX's vision for pushing the boundaries of spinal healthcare.

​

Noteworthy is Dr. Costigan's belief in the NANISX technology portfolio, demonstrated through his active involvement and voluntary efforts to foster partnerships for distribution with major industry players such as NuVasive and Alphatec. His influential network and ability to secure essential meetings and product demonstrations are invaluable assets to NANISX.

​

In his collaborative role, Dr. Costigan works closely with the entire NANISX team, from engineers to sales and executive leadership, contributing significantly to the enhancement of products and instruments. His insights and feedback continue to be instrumental in steering NANISX towards excellence.  He holds a pivotal position in shaping strategic direction and fostering partnerships. 

​

KIC Ventures expresses sincere gratitude for Dr. Costigan's unwavering dedication to making NANISX a global leader in outpatient spine surgery technologies. As Chief Medical Officer, his wealth of experience and guidance will be pivotal in making informed decisions, studying clinical problems, and developing cutting-edge technologies and techniques backed by investments in research.

​

Congratulations to Dr. William Costigan on his well-deserved appointment, and KIC Ventures eagerly anticipates the positive impact he will make in shaping the future of NANISX.